Brief: Bioretec Receives CE Mark Approval For Remeos Trauma Screw Product Portfolio
Feb 3 (Reuters) - Bioretec Oy BRETEC.HE :
* BIORETEC LTD. RECEIVES CE MARK APPROVAL FOR REMEOS™ TRAUMA
SCREW
PRODUCT PORTFOLIO, ALLOWING MARKET LAUNCH IN EUROPE
Source text: ID:nWkr3P2HK4
Further company coverage: BRETEC.HE
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;;))
Recent news on Bioretec Oy
See all newsBrief: Bioretec Initiates Change Negotiations
Brief: Bioretec Gets Marketing Authorization From FDA
Brief: Bioretec Receives FDA 510(K) Clearance For Its Activascrew Cannulated Com Bioabsorbable Compression Screw
Finland's Bioretec H1 revenue rises 12%, loss narrows
Brief: Bioretec Q2 Net Sales EUR 1.1 Million